Journals / Türk Kardiyoloji Derneği Arşivi / 2020 / Cilt: 48 - Sayı: 2

Markers of coagulation and fibrinolysis do not detect or predict the presence of left atrial appendage thrombus in patients with atrial fibrillation

Atriyal fibrilasyonu olan hastalarda pıhtılaşma ve fibrinolizis belirteçleri sol atriyal trombüs varlığını belirleyemiyor veya öngöremiyor

Pages
109–115
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The LAA thrombus (+) group had significantly higher rates of heart failure, peripheral artery disease, coronaryartery disease, and chronic obstructive pulmonary disease(p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: This study was designed to evaluate the roleof hemostatic variables in arterial blood serum in left atrialthrombosis and to define any hemostatic variables, such asserum biomarkers, that could potentially reduce the needfor transesophageal echocardiography.Methods: This study included patients with non-valvularasymptomatic atrial fibrillation (AF), either paroxysmal, persistent, or chronic.
📊
Key Findings & Data:The presence of an left atrial appendix(LAA) thrombus was used to form 2 groups: thrombus (+)and thrombus (-).
💡
Conclusion & Impact:The LAA thrombus (+) group had significantly higher rates of heart failure, peripheral artery disease, coronaryartery disease, and chronic obstructive pulmonary disease(p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: This study was designed to evaluate the roleof hemostatic variables in arterial blood serum in left atrialthrombosis and to define any hemostatic variables, such asserum biomarkers, that could potentially reduce the needfor transesophageal echocardiography.Methods: This study included patients with non-valvularasymptomatic atrial fibrillation (AF), either paroxysmal, persistent, or chronic. The presence of an left atrial appendix(LAA) thrombus was used to form 2 groups: thrombus (+)and thrombus (-). The serum levels of the thrombotic/fibrinolytic markers including beta-thromboglobulin, prothrombin fragment 1+2, thrombin/antithrombin complex, humanplasminogen activator inhibitor-1/tissue plasminogen activator complex, and D-dimer were compared between 2groups.Results: The mean age of the study population was65.6±12.2 years (range: 30–96 years), and 33 (61.1%) patients were male. Fourteen (25.9%) patients had an LAAthrombus and 40 patients did not. Two groups did not differsignificantly with regard to any of the coagulation/fibrinolysismarkers. The LAA thrombus (+) group had significantly higher rates of heart failure, peripheral artery disease, coronaryartery disease, and chronic obstructive pulmonary disease(p

Özet

Amaç: Sol atriyal trombozis varlığında arter kan serumundaki hemostatik değişkenlerin rolünü değerlendirmek. Serum biyobelirteçleri gibi transözofageal ekokardiyografi ihtiyacını potansiyel olarak azaltabilecek olan hemostatik değişkenleri tanımlamak. Yöntemler: Bu çalışmaya non-valvüler asemptomatik atriyal fibrilasyonlu (AF); paroksismal, persistent veya kronik, hastalar alındı. Hastalar sol atriyal apendiks (SAA) trombüsünün varlığına göre, SAA trombüsü olanlar (Grup 1) ve SAA trombüsü olmayanlar (Grup 2) olmak üzere iki gruba ayırıldı. Bu iki grup arasında serum trombotik/fibrinolitik belirteçlerinin (beta-tromboglobulin, protrombin fragmanı 1 + 2, trombin/antitrombin kompleksi, insan PAI-1/tPA kompleksi ve D-dimer) düzeyleri arasındaki fark karşılaştırıldı. Bulgular: Çalışma popülasyonunun yaş ortalaması 65.6±12.2 yıldı (dağılım 30–96 yaş) ve 33’ü (%61.1) erkekti. On dört (%25.9) hastada SAA trombüsü vardı, 40 hastada yoktu. İki gruptada pıhtılaşma / fibrinoliz belirteçlerinin herhangi birine göre anlamlı bir farklılık göstermedi. SAA trombüs (+) grubu, kalp yetmezliği, periferik arter hastalığı, koroner arter hastalığı ve kronik obstrüktif akciğer hastalığı oranlarında anlamlı olarak daha yüksek oranlara sahipti (p

🔖

Cite This Article

HASIRCI, S., DOĞANÖZÜ, E., SADE, L. E., MÜDERRİSOĞLU, İ. H., ÖZİN, M. B., ÇİFTCİ, O., YILMAZ, K. C., KARACAĞLAR, E. (2022). Markers of coagulation and fibrinolysis do not detect or predict the presence of left atrial appendage thrombus in patients with atrial fibrillation. Türk Kardiyoloji Derneği Arşivi, Cilt: 48 - Sayı: 2, 109–115. https://ajindex.com/articles/631943

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Kannel WB, Wolf PA, Benjamin EJ, Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 1998;82:2N–9N
  2. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991;22:983–8
  3. Lip GY. Does atrial fibrillation confer a hypercoagulable state? Lancet 1995;346:1313–4
  4. Castellano JM, Chinitz J, Willner J, Fuster V. Mechanisms of stroke in atrial fibrillation. Card Electrophysiol Clin 2014;6:5–15
  5. Watson T, Shantsila E, Lip GY. Mechanisms of thrombogenesis in atrial fibrillation: Virchow’s triad revisited. Lancet 2009;373:155–66
  6. Fatkin D, Scalia G, Jacobs N, Burstow D, Leung D, Walsh W, et al. Accuracy of biplane transesophageal echocardiography in detecting left atrial thrombus. Am J Cardiol 1996;77321–3
  7. Wann LS, Curtis AB, January CT, Ellenbogen KA, Lowe JE, Estes NA 3rd, et al. ACCF/AHA/HRS. 2011 ACCF/AHA/ HRS focused update on the management of patients with atrial fibrillation (updating the 2006 guideline) a report of the American college of cardiology foundation/American heart association task force on practice guidelines. J Am Coll Cardiol 2011;57223–42
  8. Daniel WG, Erbel R, Kasper W, Visser CA, Engberding R, Sutherland GR, et al. Safety of transesophageal echocardiography. A multicenter survey of 10,419 examinations. Circulation 1991;83:817–21
  9. Heppell RM, Berkin KE, McLenachan JM, Davies JA. Haemostatic and haemodynamic abnormalities associated with left atrial thrombosis in non-rheumatic atrial fibrillation. Heart 1997;77:407–11
  10. Kubisz P, Pafiízek M, Seghier F, Holan J, Cronberg S. Relationship between platelet aggregation and plasma betathromboglobulin levels in arteriovascular and renal diseases. Atherosclerosis 1985;55:363–8
  11. Pelzer H, Schwarz A, Stüber W. Determination of human prothrombin activation fragment 1+2 in plasma with an antibody against a synthetic peptide. Thromb Haemost 1991;65:153–9
  12. Yu X, Tian Y, Wang K, Wang YL, Lv GY, Tian GG. Effect of ulinastatin combined rivaroxaban on deep vein thrombosis in major orthopedic surgery. Asian Pac J Trop Med 2014;7:918– 21
  13. Ginsberg JS, Brill-Edwards P, Panju A, Patel A, McGinnis J, Smith F, et al. Pre-operative plasma levels of thrombin-antithrombin III complexes correlate with the development of venous thrombosis after major hip or knee surgery. Thromb Haemost 1995;74:602–5
  14. De Prost D, Ollivier V, Vie P,